Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Mesylate and Hydroxyurea in Recurrent/Progressive Meningioma
NCT00354913Phase 2Completed
- Sponsor
- Duke University
- Start
- May 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in meningioma, sponsored by Duke University. Started May 2005; status: completed.
02
Drugs
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00354913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354913.